Annual Cash & Cash Equivalents:
$162.19M+$10.39M(+6.85%)Summary
- As of today, TECH annual cash & cash equivalents is $162.19 million, with the most recent change of +$10.39 million (+6.85%) on June 30, 2025.
- During the last 3 years, TECH annual cash & cash equivalents has fallen by -$10.38 million (-6.02%).
- TECH annual cash & cash equivalents is now -49.09% below its all-time high of $318.57 million, reached on June 30, 2014.
Performance
TECH Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$144.96M-$17.22M(-10.62%)Summary
- As of today, TECH quarterly cash & cash equivalents is $144.96 million, with the most recent change of -$17.22 million (-10.62%) on September 30, 2025.
- Over the past year, TECH quarterly cash & cash equivalents has dropped by -$42.58 million (-22.70%).
- TECH quarterly cash & cash equivalents is now -49.56% below its all-time high of $287.39 million, reached on September 30, 2020.
Performance
TECH Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TECH Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +6.8% | -22.7% |
| 3Y3 Years | -6.0% | -28.6% |
| 5Y5 Years | +10.6% | -49.6% |
TECH Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -10.2% | +6.8% | -29.1% | +6.9% |
| 5Y | 5-Year | -18.5% | +10.6% | -49.6% | +6.9% |
| All-Time | All-Time | -49.1% | >+9999.0% | -49.6% | >+9999.0% |
TECH Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $144.96M(-10.6%) |
| Jun 2025 | $162.19M(+6.8%) | $162.19M(+15.3%) |
| Mar 2025 | - | $140.67M(-20.8%) |
| Dec 2024 | - | $177.55M(-5.3%) |
| Sep 2024 | - | $187.54M(+22.7%) |
| Jun 2024 | $151.79M(-15.9%) | $152.86M(+5.2%) |
| Mar 2024 | - | $145.31M(+7.1%) |
| Dec 2023 | - | $135.65M(-8.8%) |
| Sep 2023 | - | $148.66M(-27.2%) |
| Jun 2023 | $180.57M(+4.6%) | $204.31M(+30.0%) |
| Mar 2023 | - | $157.20M(-20.1%) |
| Dec 2022 | - | $196.76M(-3.1%) |
| Sep 2022 | - | $203.07M(-17.8%) |
| Jun 2022 | $172.57M(-13.3%) | $247.03M(+6.9%) |
| Mar 2022 | - | $231.17M(-17.1%) |
| Dec 2021 | - | $278.98M(+18.7%) |
| Sep 2021 | - | $235.06M(+1.5%) |
| Jun 2021 | $199.09M(+35.8%) | $231.55M(-16.2%) |
| Mar 2021 | - | $276.24M(-2.4%) |
| Dec 2020 | - | $282.95M(-1.5%) |
| Sep 2020 | - | $287.39M(+6.1%) |
| Jun 2020 | $146.63M(+45.3%) | $270.89M(+3.8%) |
| Mar 2020 | - | $261.09M(+43.6%) |
| Jun 2019 | $100.89M(-17.3%) | - |
| Jun 2018 | $121.99M(+33.2%) | $181.75M(+15.2%) |
| Jun 2017 | $91.61M(+42.6%) | $157.71M(+80.7%) |
| Jun 2016 | $64.24M(+17.8%) | - |
| Sep 2015 | - | $87.27M(-37.6%) |
| Jun 2015 | $54.53M(-82.9%) | - |
| Dec 2014 | - | $139.94M(-24.2%) |
| Jun 2014 | $318.57M(+94.5%) | - |
| Sep 2013 | - | $184.70M(+31.2%) |
| Jun 2013 | $163.79M(+40.4%) | - |
| Jun 2012 | $116.67M(+50.3%) | - |
| Jun 2011 | $77.61M(-17.6%) | $140.81M(-34.2%) |
| Mar 2011 | - | $213.90M(-14.3%) |
| Jun 2010 | $94.14M(-41.5%) | - |
| Dec 2009 | - | $249.48M(+73.3%) |
| Jun 2009 | $160.94M(-3.6%) | - |
| Dec 2008 | - | $143.96M(+14.0%) |
| Jun 2008 | $166.99M(+23.3%) | - |
| Jun 2007 | $135.49M(+51.2%) | - |
| Dec 2006 | - | $126.31M(+74.4%) |
| Jun 2006 | $89.63M(+11.6%) | - |
| Jun 2005 | $80.34M | - |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2005 | - | $72.43M(-25.4%) |
| Jun 2004 | $51.20M(+30.0%) | - |
| Jun 2003 | $39.37M(+49.2%) | - |
| Jun 2002 | $26.39M(+24.1%) | - |
| Jun 2001 | $21.27M(+22.5%) | $97.07M(+37.2%) |
| Sep 2000 | - | $70.75M(+143.0%) |
| Jun 2000 | $17.36M(+35.6%) | - |
| Jun 1999 | $12.80M(-53.3%) | $29.11M(+13.0%) |
| Mar 1999 | - | $25.75M(-39.7%) |
| Jun 1998 | $27.40M(+218.6%) | $42.69M(+17.1%) |
| Mar 1998 | - | $36.47M(+268.4%) |
| Dec 1997 | - | $9.90M(+8.8%) |
| Sep 1997 | - | $9.10M(+5.8%) |
| Jun 1997 | $8.60M(+16.2%) | $8.60M(+59.3%) |
| Mar 1997 | - | $5.40M(-22.9%) |
| Dec 1996 | - | $7.00M(+25.0%) |
| Sep 1996 | - | $5.60M(-24.3%) |
| Jun 1996 | $7.40M(+39.6%) | $7.40M(+29.8%) |
| Mar 1996 | - | $5.70M(+39.0%) |
| Dec 1995 | - | $4.10M(-31.7%) |
| Sep 1995 | - | $6.00M(+13.2%) |
| Jun 1995 | $5.30M(-10.2%) | $5.30M(+1.9%) |
| Mar 1995 | - | $5.20M(+15.6%) |
| Dec 1994 | - | $4.50M(-25.0%) |
| Sep 1994 | - | $6.00M(+1.7%) |
| Jun 1994 | $5.90M(+47.5%) | $5.90M(+15.7%) |
| Mar 1994 | - | $5.10M(+50.0%) |
| Dec 1993 | - | $3.40M(0.0%) |
| Sep 1993 | - | $3.40M(-15.0%) |
| Jun 1993 | $4.00M(-11.1%) | $4.00M(+60.0%) |
| Mar 1993 | - | $2.50M(+19.0%) |
| Dec 1992 | - | $2.10M(-16.0%) |
| Sep 1992 | - | $2.50M(-44.4%) |
| Jun 1992 | $4.50M(+125.0%) | $4.50M(+15.4%) |
| Mar 1992 | - | $3.90M(+77.3%) |
| Dec 1991 | - | $2.20M(+22.2%) |
| Sep 1991 | - | $1.80M(-10.0%) |
| Jun 1991 | $2.00M(+53.8%) | $2.00M(+33.3%) |
| Mar 1991 | - | $1.50M(0.0%) |
| Dec 1990 | - | $1.50M(-28.6%) |
| Sep 1990 | - | $2.10M(+61.5%) |
| Jun 1990 | $1.30M(+30.0%) | $1.30M(-7.1%) |
| Mar 1990 | - | $1.40M(+75.0%) |
| Dec 1989 | - | $800.00K(-20.0%) |
| Sep 1989 | - | $1.00M |
| Jun 1989 | $1.00M | - |
FAQ
- What is Bio-Techne Corporation annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Bio-Techne Corporation?
- What is Bio-Techne Corporation annual cash & cash equivalents year-on-year change?
- What is Bio-Techne Corporation quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Bio-Techne Corporation?
- What is Bio-Techne Corporation quarterly cash & cash equivalents year-on-year change?
What is Bio-Techne Corporation annual cash & cash equivalents?
The current annual cash & cash equivalents of TECH is $162.19M
What is the all-time high annual cash & cash equivalents for Bio-Techne Corporation?
Bio-Techne Corporation all-time high annual cash & cash equivalents is $318.57M
What is Bio-Techne Corporation annual cash & cash equivalents year-on-year change?
Over the past year, TECH annual cash & cash equivalents has changed by +$10.39M (+6.85%)
What is Bio-Techne Corporation quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of TECH is $144.96M
What is the all-time high quarterly cash & cash equivalents for Bio-Techne Corporation?
Bio-Techne Corporation all-time high quarterly cash & cash equivalents is $287.39M
What is Bio-Techne Corporation quarterly cash & cash equivalents year-on-year change?
Over the past year, TECH quarterly cash & cash equivalents has changed by -$42.58M (-22.70%)